G. Skrepnek

发表

Summary of Functional Forms Involving Logarithms for a Simple Regression Equation

G. Skrepnek, 2005 .

Reasons provided by prescribers when overriding drug-drug interaction alerts.

Donna C. Dare, John E. Murphy, D. Malone, 2007, The American journal of managed care.

Potential drug-drug interactions within Veterans Affairs medical centers.

John E. Murphy, D. Malone, J. Abarca, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality

E. Armstrong, G. Skrepnek, D. Sherrill, 2012, COPD.

Workload and availability of technology in metropolitan community pharmacies.

John E. Murphy, D. Malone, J. Abarca, 2006, Journal of the American Pharmacists Association : JAPhA.

Pharmacist Workload and Pharmacy Characteristics Associated With the Dispensing of Potentially Clinically Important Drug-Drug Interactions

Amy J Grizzle, Daniel C Malone, Raymond L Woosley, 2007, Medical care.

Cost-effectiveness of medication therapy management in part D diabetic enrollees

G. Skrepnek, Mignonne C. Guy, E. Olvey, 2014 .

Preferences of patients and oncologists for advanced ovarian cancer treatment-related health States

Lisa M. Hess, Daniel C. Malone, Pamela G. Reed, 2010 .

Oncologist preferences for health states associated with the treatment of advanced ovarian cancer

D. Malone, E. Armstrong, G. Skrepnek, 2010, Applied health economics and health policy.

Potential determinants of prescribers' drug-drug interaction knowledge.

D. Malone, E. Armstrong, G. Skrepnek, 2008, Research in social & administrative pharmacy : RSAP.

Use of reflective portfolios in health sciences education.

Cecilia M. Plaza, G. Skrepnek, J. Draugalis, 2007, American journal of pharmaceutical education.

Quality‐adjusted time without symptoms or toxicity (Q‐TWiST): patient‐reported outcome or mathematical model? A systematic review in cancer

G. Skrepnek, W. Tate, 2015, Psycho-oncology.

Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department

G. Skrepnek, N. Schwier, J. J. Cannedy, 2020, Advanced emergency nursing journal.

Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma*

D. Malone, E. Armstrong, G. Skrepnek, 2008, Current medical research and opinion.

A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings

G. Skrepnek, L. M. Tidmore, 2022, Alzheimer disease and associated disorders.

Sleep-Disordered Breathing is Associated With Increased Mortality in Hospitalized Infants With Congenital Heart Disease.

S. Parthasarathy, G. Skrepnek, W. Morgan, 2018, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

1 As submitted to : Journal of Medical Economics And later published as : Long-Term Persistency and Costs Associated with the Use of Iron Chelation Therapies in the Treatment of Sickle Cell Disease within Medicaid Programs in the United States

E. Armstrong, G. Skrepnek, S. Ballas, 2017 .

Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs

E. Armstrong, G. Skrepnek, S. Ballas, 2013, Journal of medical economics.

Effect of epidural analgesia on postoperative complications following pancreaticoduodenectomy.

E. Ong, G. Skrepnek, A. Patanwala, 2012, American journal of surgery.

Decision-making associated with drug candidates in the biotechnology research and development (R&D) pipeline

G. Skrepnek, J. Sarnowski, 2007 .

A Propensity-Matched Analysis Between Standard Versus Tapered Oral Vancomycin Courses for the Management of Recurrent Clostridium difficile Infection

G. Skrepnek, S. Giancola, C. Gentry, 2017, Open forum infectious diseases.

An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care

D. Malone, E. Armstrong, G. Skrepnek, 2005, Current medical research and opinion.

RESEARCH ARTICLES Curriculum Mapping in Program Assessment and Evaluation

Cecilia M. Plaza, G. Skrepnek, J. Draugalis, 2007 .

Cost-effectiveness of urokinase and alteplase for treatment of acute peripheral artery disease: comparison in a decision analysis model.

G. Skrepnek, E. Olvey, P. Nolan, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

State Medicaid Programs Bring Managed Care Tenets to Fee for Service

G. Skrepnek, Shellie L Keast, Nancy J Nesser, 2016, Journal of managed care & specialty pharmacy.

Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia

G. Skrepnek, K. Pareja, Shellie L Keast, 2022, Current medical research and opinion.

Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection

G. Skrepnek, C. Gentry, Riley J. Williams, 2018, Journal of clinical pharmacy and therapeutics.

Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation

G. Skrepnek, C. Benson, S. Grabich, 2022, Advances in Therapy.

Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012–2016

G. Skrepnek, T. Alfieri, Shellie L Keast, 2018, Medical care.

The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis

Grant H. Skrepnek, G. Skrepnek, 2007, PharmacoEconomics.

Micafungin Therapy for Symptomatic Candiduria in Hospitalized Patients: A Review of 14 Cases

G. Skrepnek, Michelle R. Salvaggio, Katherine E. Kupiec, 2017 .

Peginterferon alfa‐2a versus Peginterferon alfa‐2b as Initial Treatment of Hepatitis C Virus Infection: A Cost‐Utility Analysis from the Perspective of the Veterans Affairs Health Care System

D. Malone, E. Armstrong, G. Skrepnek, 2007, Pharmacotherapy.

Cost‐Efficacy of Imatinib versus Allogeneic Bone Marrow Transplantation with a Matched Unrelated Donor in the Treatment of Chronic Myelogenous Leukemia: A Decision‐Analytic Approach

G. Skrepnek, E. Ballard, 2005, Pharmacotherapy.

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial*

E. Armstrong, G. Skrepnek, D. Ventura, 2007, Current medical research and opinion.

A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006–2010

D. Armstrong, J. Mills, G. Skrepnek, 2015, PloS one.

Emergency department visits in the United States for pediatric depression: estimates of charges and hospitalization.

Ivo Abraham, Marion Slack, G. Skrepnek, 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Determinants of life expectancy in the Eastern Mediterranean Region.

G. Skrepnek, A. Gilligan, 2015, Health policy and planning.

Determinants of life expectancy in the Eastern

G. Skrepnek, A. Gilligan, Mediterranean Region, 2014 .

Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA

G. Skrepnek, A. Altyar, Lama Kordi, 2015, BMJ Open.

The cost-effectiveness of sertraline in the treatment of depression

G. Skrepnek, E. Olvey, 2008 .

Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children.

Peter N. Johnson, G. Skrepnek, C. Golding, 2017, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Induction Dose of Propofol for Pediatric Patients Undergoing Procedural Sedation in the Emergency Department

G. Skrepnek, A. Patanwala, Christopher J. Edwards, 2012, Pediatric emergency care.

Propofol-associated QTc prolongation

G. Skrepnek, Toni L. Ripley, M. Scalese, 2016, Therapeutic advances in drug safety.

Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended?

Peter N. Johnson, G. Skrepnek, Jamie L. Miller, 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy

G. Skrepnek, Jamie L. Miller, Katherine E. Kupiec, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer.

D. Alberts, G. Skrepnek, D. Roe, 2018, The American journal of medicine.

The Role of Administrative Mentoring in the Pharmacy Deanship

Cecilia M. Plaza, G. Skrepnek, J. Draugalis, 2004 .

Cost analysis of a disease management programme for adult Medicaid clients with schizophrenia

E. Armstrong, G. Skrepnek, B. Martin, 2007 .

Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.

J. Hay, N. Watts, B. Seal, 2010, General dentistry.

Book Review: Stem cell wars: Inside stories from the Frontlines

G. Skrepnek, 2008 .

Cost–effectiveness of HMG-CoA reductase inhibitors in the treatment of dyslipidemia and prevention of CHD

G. Skrepnek, 2005, Expert review of pharmacoeconomics & outcomes research.

Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study.

G. Skrepnek, R. Williams, C. Gentry, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001–2010

G. Skrepnek, A. Baker, W. Tate, 2014, Leukemia & lymphoma.

Incremental Effects of Concurrent Pharmacotherapeutic Regimens for Heart Failure on Hospitalizations and Costs

D. Malone, J. Abarca, E. Armstrong, 2005 .

Curriculum mapping in program assessment and evaluation.

Cecilia M. Plaza, Karen Ann Sauer, G. Skrepnek, 2007, American journal of pharmaceutical education.

A meta‐analysis of the efficacy of intraperitoneal cisplatin for the front‐line treatment of ovarian cancer

D. Alberts, D. Malone, G. Skrepnek, 2007, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Accounting- versus economic-based rates of return: implications for profitability measures in the pharmaceutical industry.

G. Skrepnek, 2004, Clinical therapeutics.

Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma.

G. Skrepnek, Stan V Skrepnek, 2004, The American journal of managed care.

An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma.

G. Skrepnek, Stan V Skrepnek, 2004, The American journal of managed care.

The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression

G. Skrepnek, Jamie L. Miller, S. Woo, 2023, The Annals of pharmacotherapy.

PUK2 LONGITUDINAL DECLINE OF RENAL FUNCTION IN HYPERTENSIVE VETERANS

J. Ranger-Moore, G. Skrepnek, D. Malone, 2008 .

Persistence, Adherence, and Risk of Discontinuation Associated with Commonly Prescribed Antihypertensive Drug Monotherapies

G. Skrepnek, W. Elliott, C. Plauschinat, 2007, The Journal of the American Board of Family Medicine.

Health Care Expenditures, Hospitalizations, and Productivity Associated With Cancer in US Employer Settings

D. Alberts, G. Skrepnek, S. Sullivan, 2012, Journal of occupational and environmental medicine.

Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality

G. Skrepnek, Jamie L. Miller, Toni L. Ripley, 2018, American Journal of Cardiovascular Drugs.

Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S.

David G Armstrong, D. Armstrong, L. Lavery, 2017, Diabetes Care.

Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010.

D. Armstrong, J. Mills, G. Skrepnek, 2014, Journal of vascular surgery.

Intramuscular Interferon Beta-1a and Evolving Treatment Options and Outcomes Measurement for MS: Considerations for Managed Care

J. Menzin, M. Friedman, G. Skrepnek, 2013, Journal of managed care pharmacy : JMCP.

Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies

G. Skrepnek, E. Olvey, G. Owens, 2013, Journal of managed care pharmacy : JMCP.

An analysis of security price risk and return among publicly traded pharmacy corporations.

G. Skrepnek, A. Gilligan, 2013, Research in social & administrative pharmacy : RSAP.

Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children.

Peter N. Johnson, G. Skrepnek, Jamie L. Miller, 2019, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Patient safety and medication errors

G. Skrepnek, J. Bootman, 2005 .

Pharmacoeconomics and developing nations

G. Skrepnek, L. Villa, 2012 .

Administrative Career Planning: A Ten-Year Update of the Pharmacy Deanship

Marion K. Slack, JoLaine R. Draugalis, Cecilia M. Plaza, 2004, American Journal of Pharmaceutical Education.

Career Skills Assessment in a Doctor of Pharmacy Curriculum

Melissa S Medina, G. Skrepnek, Jamie L. Miller, 2018, American Journal of Pharmaceutical Education.

Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost.

G. Skrepnek, Shellie L Keast, Terry Cothran, 2018, Journal of the American Pharmacists Association : JAPhA.

Is scorpion antivenom cost-effective as marketed in the United States?

E. Armstrong, G. Skrepnek, L. Boyer, 2013, Toxicon : official journal of the International Society on Toxinology.

Development of computerized alerts with management strategies for 25 serious drug-drug interactions.

Amy J Grizzle, Daniel C Malone, John E. Murphy, 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

The effect of merger and acquisition activity on shareholder returns in the pharmaceutical industry

G. Skrepnek, K. Lawson, 2001 .

National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US.

K. Farmer, G. Skrepnek, Shellie L Keast, 2018, Journal of evaluation in clinical practice.

Foot-in-Wallet Disease: Tripped Up by “Cost-Saving” Reductions?

D. Armstrong, J. Mills, G. Skrepnek, 2014, Diabetes Care.

Prescribers’ Knowledge of and Sources of Information for Potential Drug-Drug Interactions

Daniel C Malone, Raymond L Woosley, Jacob Abarca, 2008, Drug safety.

Cost–utility comparison of escitalopram and sertraline in the treatment of major depressive disorder

E. Armstrong, G. Skrepnek, M. Erder, 2007, Current medical research and opinion.

Econometric approaches in evaluating costs and outcomes within pharmacoeconomic analyses

A. Sahai, G. Skrepnek, E. Olvey, 2012 .

Pharmacoeconomic analyses of treatments for rare disease

G. Skrepnek, J. Fishman, 2012 .

An assessment of health and work productivity measurement in employer settings

G. Skrepnek, S. Sullivan, Rick Nevins, 2012 .

Health Economic and Outcomes Research in Cancer

G. Skrepnek, 2016 .

Regression Methods in the Empiric Analysis of Health Care Data

G. Skrepnek, 2005, Journal of managed care pharmacy : JMCP.

Medication therapy problems assessment within medication history objective structured clinical examinations using standardized patients versus peer actors

G. Skrepnek, S. Neely, Paul M. Boylan, 2023, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

Community pharmacy managers' perception of computerized drug-drug interaction alerts.

Amy J Grizzle, Daniel C Malone, Raymond L Woosley, 2006, Journal of the American Pharmacists Association : JAPhA.

Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S.

D. Armstrong, L. Lavery, J. Mills, 2017, Diabetes Care.